Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 20:07:19
CURE Pharma Hldg Rg (US Other OTC (Pink Sheets))
Závěr k 12.2.2026 Změna (%) Změna (USD) Objem obchodů (ks)
0,0002 0,00 0,00 1 000
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiAvenir Wellness Solutions Inc
TickerAVRW
Kmenové akcie:Ordinary Shares
RICAVRW.PK
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky30.09.2024
Počet zaměstnanců k 16.05.2024 11
Akcie v oběhu k 30.09.2024 78 925 168
MěnaUSD
Kontaktní informace
Ulice15233 Ventura Blvd., Suite 420
MěstoSHERMAN OAKS
PSČ91403
ZeměUnited States
Kontatní osobaMichael Bayes
Funkce kontaktní osobyPresident, Liviakis Financial Communications, Inc.
Telefon14 242 738 675
Fax13026974597
Kontatní telefon14 153 894 670

Business Summary: Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production and sale of the Company’s wellness and beauty products. Sera Labs creates products that use science-backed, proprietary oral and topical formulations. The Company sells over 25 products under the brand names Seratopical, Seratopical Revolution SeraLabs, and Nutri-Stri. Sera Labs products are sold direct-to-consumer via online Website orders, including opt-in subscribe and save option, and also online and in-store at national drug, mass retailers, grocery chains and convenience stores and on Amazon.com.
Financial Summary: BRIEF: For the nine months ended 30 September 2024, Avenir Wellness Solutions Inc revenues decreased 72% to $919K. Net loss decreased 20% to $2.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Selling, general and administrative expe decrease of 63% to $1.2M (expense), Advertising Expense decrease of 78% to $514K (expense).
Odvětvová klasifikace
TRBC2012Software (NEC)
MGINDUSTRYSoftware & Programming
MGSECTORTechnology
NAICSSoftware Publishers
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Food (Health) Supplement Stores
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Food (Health) Supplement Stores
SICPrepackaged Software
SICPharmaceutical Preparations



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, DirectorNancy Duitch69
Chief Financial Officer and Accounting Officer, Treasurer, SecretaryJoel Bennett5622.07.202222.07.2022